[Pharmacokinetics of ceftizoxime with and without probenecid]
- PMID: 6285937
[Pharmacokinetics of ceftizoxime with and without probenecid]
Abstract
Serum concentrations and urinary recovery of ceftizoxime were investigated in 18 healthy volunteers. The substance was given as a bolus (2 min) i.v. injection. In volunteers the injection was preceded by orally administered probenecid, 500 mg, 7 and 1 h before (Group II); the remaining 12 volunteers received medication. 5 min after the injection, the serum concentration in Group I was 107 +/- 22 micrograms/ml and in II 93 +/- 18 micrograms/ml in the mean; 30 min after the injection in I 45 +/- 8 micrograms/ml and 44 +/- 10 micrograms/ml in II. The further of the serum concentration was slower in II than in I: serum concentration 6 h after the injection was 2.6 +/- 0.9 micrograms/ml in I and 4.4 +/- 2 micrograms/ml in II. During the first 8-h period 81% of the administered cephalosporin was recovered in the urine of I and 58% in the urine of II. t/2 beta was calculated for I with 1.76 h and 2.13 h for II. The distribution volume was equal, so that the differences in serum concentrations could be explained by the reduced renal clearance: from 2.1 to 1.4 ml/s. Because the comparison was done with two independent groups and furthermore only 6 volunteers participated in the probenecid group, only the difference in the urine in the first 2 h was statistically significant.
Similar articles
-
Cephalosporin-probenecid drug interactions.Clin Pharmacokinet. 1993 Apr;24(4):289-300. doi: 10.2165/00003088-199324040-00003. Clin Pharmacokinet. 1993. PMID: 8491057 Review.
-
Effect of probenecid on the pharmacokinetics of ceftizoxime.J Antimicrob Chemother. 1983 Aug;12(2):147-55. doi: 10.1093/jac/12.2.147. J Antimicrob Chemother. 1983. PMID: 6311785 Clinical Trial.
-
[Tissue concentration of ceftizoxime in the lung].Arzneimittelforschung. 1983;33(3):427-9. Arzneimittelforschung. 1983. PMID: 6307319 German.
-
[Pharmacokinetics of mezlocillin. Comparison with ampicillin and influence of probenecid (author's transl)].Nouv Presse Med. 1982 Feb 4;11(5 Pt 2):347-52. Nouv Presse Med. 1982. PMID: 6460974 Clinical Trial. French.
-
Pharmacokinetics of intravenous ceftizoxime in patients on continuous ambulatory peritoneal dialysis.Clin Nephrol. 1985 Mar;23(3):120-4. Clin Nephrol. 1985. PMID: 3857136
Cited by
-
Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs. 1985 Apr;29(4):281-329. doi: 10.2165/00003495-198529040-00001. Drugs. 1985. PMID: 3888599 Review.
-
[Clinical studies of the efficacy and tolerance of cefotaxime, ceftizoxime and ceftriaxone in patients with complicated urinary tract infections].Infection. 1983 Nov-Dec;11(6):296-301. doi: 10.1007/BF01641350. Infection. 1983. PMID: 6321356 Clinical Trial. German.
-
Clinical pharmacokinetics of the third generation cephalosporins.Clin Pharmacokinet. 1985 Mar-Apr;10(2):101-43. doi: 10.2165/00003088-198510020-00001. Clin Pharmacokinet. 1985. PMID: 3888488 Review.
-
Cephalosporin-probenecid drug interactions.Clin Pharmacokinet. 1993 Apr;24(4):289-300. doi: 10.2165/00003088-199324040-00003. Clin Pharmacokinet. 1993. PMID: 8491057 Review.